title: Stereotactic ablative radiotherapy and surgery: two gold standards for early-stage non-small cell lung cancer?
abstract: There is growing clinical equipoise between surgery and stereotactic ablative radiotherapy (SABR) in the management of early-stage non-small cell lung cancer (ES-NSCLC). Increasing evidence suggest similar outcomes between these modalities. Through the guidance of a multidisciplinary team, a shared decision making approach in this setting in favoured.
authors.affiliation: Department of Radiation Oncology, London Regional Cancer Program, Western University, London, ON, Canada.
authors.forename: Hanbo
authors.initials: H
authors.lastname: Chen
authors.affiliation: Department of Radiation Oncology, London Regional Cancer Program, Western University, London, ON, Canada.
authors.forename: Alexander V
authors.initials: AV
authors.lastname: Louie
keywords: Carcinoma; comparative effectiveness research; non-small cell lung; radiosurgery; retrospective studies; thoracic surgical procedures